Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Intimate partner violence.

Jennifer Gunter¹

¹Department of Obstetrics/Gynecology, Kaiser Northern California, 2238 Geary Boulevard, San Francisco, CA 94115, USA. jennifer.gunter@kp.org

Obstetrics and Gynecology Clinics of North America

|October 9, 2007

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Mixed-Chirality Prohibitin Peptide: D-(RLARLAR)2 Enhances Stability and <i>In Vivo</i> Effects on Obesity.

Journal of the American Chemical Society·2025

Same author

Protocol for a pragmatic trial to enhance quality safety, and patient experience in chronic obstructive pulmonary disease (EQuiP-COPD).

Contemporary clinical trials·2025

Same author

Bone marrow adipocytes in cancer: Mechanisms, models, and therapeutic implications.

Biomaterials·2025

Same author

Mitochondrial Oxygen Consumption and Immunocytochemistry of Human Dental Pulp Stem Cell Following 808 nm PBM Therapy: A 3D Cell Culture Study.

Journal of biophotonics·2025

Same author

Assessment of the influence of 660 and 808-nm PBM treatments on mitochondrial oxygen consumption of MG-63 osteoblast: a 3D cell culture study.

Lasers in medical science·2025

Same author

Comparative Analysis of the Therapeutic Potential of Extracellular Vesicles Secreted by Aged and Young Bone Marrow-Derived Mesenchymal Stem Cells in Osteoarthritis Pathogenesis.

Cell proliferation·2024

Same journal

Bridging Science and Practice in Gender-Affirming Care: A Compendium for Gynecologists.

Obstetrics and gynecology clinics of North America·2026

Same journal

Evidence, Clinical Expertise, and Research Gaps in Gender-Affirming Care.

Obstetrics and gynecology clinics of North America·2026

Same journal

Evaluation and Management of the Pediatric Gender-Diverse Patient.

Obstetrics and gynecology clinics of North America·2026

Same journal

Expanding Access to Cervical Cancer Screening for Transgender and Nonbinary Individuals.

Obstetrics and gynecology clinics of North America·2026

Same journal

Updates on Breast Cancer Screening and Special Considerations for Transgender Men and Women.

Obstetrics and gynecology clinics of North America·2026

Same journal

Contraceptive Needs of the Transmasculine Patient.

Obstetrics and gynecology clinics of North America·2026

See all related articles

Intimate partner violence (IPV) affects about 60% of women and is a major health concern. Healthcare providers must screen all women for IPV and address the complex factors involved when abuse is identified.

Area of Science:

Public Health
Women's Health
Social Medicine

Background:

Intimate partner violence (IPV) is highly prevalent, affecting approximately 60% of women lifetime.
IPV is a significant cause of morbidity and mortality, particularly for reproductive-aged women, young women, and during pregnancy.

Purpose of the Study:

To emphasize the critical need for healthcare providers to screen all women for IPV.
To outline the necessary steps when a patient screens positive for IPV, including risk assessment and intervention planning.

Main Methods:

The abstract discusses the importance of provider recognition of IPV risk in all partnered women.
It highlights the need for appropriate screening, risk assessment, intervention, and documentation protocols.

Related Experiment Videos

Main Results:

Despite screening efforts, IPV rates have not significantly decreased.
This suggests that IPV is a multifaceted issue extending beyond medical concerns.

Conclusions:

Healthcare providers must screen for IPV in all women.
Addressing IPV requires a comprehensive approach considering psychological, financial, familial, cultural, and legal dimensions.